Interestingly, Hakimi AA et al. analyzed 188 ccRCC patients for genetic sequencing and prognosis and found that BAP1 and SETD2 mutations were associated with worse cancer-specific survival (CSS) [41]. This evidence concerns the gene BAP1 and nonpapillary renal cell carcinoma.